Amarin Corp. Plc (AMRN)
14.89
+0.69
(+4.86%)
USD |
NASDAQ |
Jun 09, 16:00
14.99
+0.10
(+0.67%)
After-Hours: 20:00
Amarin Research and Development Expense (Quarterly) : 4.020M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Akari Therapeutics Plc | 1.457M |
| Cellectis SA | 23.09M |
| Agenus, Inc. | 11.82M |
| Grifols SA | 105.29M |
| Trinity Biotech Plc | 1.057M |